SUNSHINE BIOPHARMA INC (SBFM)
US8677816014 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 228K 221.13% | 4.346M 1,806.14% | 24.093M 454.37% | 38.535M 59.94% | 102M 164.69% | |
| EBITDA YoY % growth | -2.428M -331.39% | -8.649M -256.17% | -4.636M 46.40% | N/A | N/A | |
| EBIT YoY % growth | -2.441M -323.05% | -8.674M -255.35% | -4.785M 44.84% | -241.74K 94.95% | 12.301M 5,188.52% | |
| Operating Margin | -1,070.61% | -199.59% | -19.86% | -0.63% | 12.06% | |
| EPS YoY % growth | N/A | N/A | N/A | -4.20 98.71% | 0.75 117.96% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | 27.34 127.34% |
| Revenue Q2Q % growth | 15.81M 105.85% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | 1.396M 217.59% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.94 98.83% | 9.18 | -10.12 | -110.24% |
| Q2 2024 Q2Q % growth | -9.94 | -7.55 | -2.39 | -31.69% |
| Q1 2024 Q2Q % growth | -40.00 | -21.22 | -18.78 | -88.54% |
| Q4 2023 Q2Q % growth | -100.00 | -61.20 | -38.80 | -63.40% |
| Q3 2023 Q2Q % growth | -80.00 -99,900.00% | -122.40 | 42.40 | 34.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 8.435M 41.60% | 12.036M | -3.601M | -29.92% |
| Q2 2024 Q2Q % growth | 9.303M 67.29% | 9.18M | 123.07K | 1.34% |
| Q1 2024 Q2Q % growth | 7.541M 54.08% | 7.14M | 401K | 5.62% |
| Q4 2023 Q2Q % growth | 7.68M 94.94% | 6.222M | 1.458M | 23.44% |
| Q3 2023 Q2Q % growth | 5.957M 4,385.69% | 6.12M | -163K | -2.66% |
| Q2 2023 Q2Q % growth | 5.561M 3,599.87% | % | ||
| Q1 2023 Q2Q % growth | 4.894M 3,888.67% | % | ||
| Q4 2022 Q2Q % growth | 3.94M 4,529.61% | % | ||
| Q3 2022 Q2Q % growth | 132.8K 163.49% | % | ||
| Q2 2022 Q2Q % growth | 150.3K 184.12% | % | ||
| Q1 2022 Q2Q % growth | 122.7K 205.99% | % | ||
| Q4 2021 Q2Q % growth | 85.1K 203.93% | % | ||
| Q3 2021 Q2Q % growth | 50.4K 193.02% | % | ||
| Q2 2021 Q2Q % growth | 52.9K 248.03% | % | ||
| Q1 2021 Q2Q % growth | 40.1K 261.26% | % | ||
| Q4 2020 Q2Q % growth | 28K 164.15% | % | ||
| Q3 2020 Q2Q % growth | 17.2K 135.62% | % | ||
| Q2 2020 Q2Q % growth | 15.2K 406.67% | % | ||
| Q1 2020 Q2Q % growth | 11.1K 5,450.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 1900% | -126.75% | -126.75% |
| Revenue | 0% | -1.9% | -14.33% | -14.33% |